Search Login Register

Epidermolysis Bullosa Summary

Description: Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.

Also Known As: Acantholysis Bullosa

Networked: 537 relevant articles (13 outcomes, 28 trials/studies) for this Disease

Key Drugs and Agents for Epidermolysis Bullosa

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. styrene-methylmethacrylate copolymer : 1 outcome 3 studies in 53 results : IBA
  2. DNA (Deoxyribonucleic Acid) : 1 outcome 1 study in 9 results : IBA
  3. Trimethoprim (Proloprim) : 1 outcome 1 study in 1 result : FDA 73 Generic
  4. Cortisone : 1 outcome in 3 results : IBA
  5. Adrenocorticotropic Hormone (ACTH) : 1 outcome in 3 results : FDA 7
  6. Tocopherols : 1 outcome in 1 result : FDA 2
  7. Collagen Type I (Type I Collagen) : 1 outcome in 1 result : IBA
  8. Bufexamac (Jomax) : 1 outcome in 1 result : IBA
  9. Non-Steroidal Anti-Inflammatory Agents (NSAIDs) : 1 outcome in 1 result : IBA
  10. pretibial Epidermolysis bullosa : 1 outcome in 1 result : IBA
Show All >>

Diseases Related to Epidermolysis Bullosa

  1. Wounds and Injuries (Trauma)
  2. Pathologic Constriction (Stenosis)
  3. Cicatrix (Scar)
  4. Leg Ulcer
  5. Skin Diseases
Show All >>

Key Therapies for Epidermolysis Bullosa

Efficacy Chart >>
  1. Transplantation (Transplant Recipients) : 1 outcome 1 study in 9 results
  2. Solid-State Lasers : 1 outcome 1 study in 1 result
  3. Transplants (Transplant) : 1 outcome in 12 results
  4. Artificial Skin : 1 outcome in 4 results
  5. General Anesthesia : 1 outcome in 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.